2022

• He, G., Dunn, H., Ahmad, K., Watson, E., Henderson, A., Tynan, D., Leaney, J., White, A., Hewitt, A., Fraser, C. (2022). Fundoscopy use in neurology departments and the utility of smartphone photography: a prospective prevalence and crossover diagnostic accuracy study amongst neurology inpatients. European Journal of Neurology, 29(8), 2463-2472. [More Information]
• Smith, J., Menzies, A., Cohen, J., Mut-Lloret, M., Ozgun, A., Spain, L., Park, J., Quach, H., Pallan, L., McQuade, J., Long, G., Carlino, M., et al (2022). Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: A multicenter case series. Melanoma Research, 32(6), 451-459. [More Information]
• Clarke, L., Bukhari, W., O'Gorman, C., Khalilidehkordi, E., Arnett, S., Woodhall, M., Prain, K., Parratt, J., Barnett, M., Marriott, M., et al (2022). Response to treatment in NMOSD: the Australasian experience. Multiple Sclerosis and Related Disorders, 58. [More Information]

2021

• Clarke, L., Arnett, S., Bukhari, W., Khalilidehkordi, E., Jimenez Sanchez, S., O'Gorman, C., Sun, J., Prain, K., Woodhall, M., Silvestrini, R., Dale, R., Hawke, S., Heard, R., Ramanathan, S., et al (2021). MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis. Frontiers in Neurology, 12, 722237. [More Information]

2020

• Khalilidehkordi, E., Clarke, L., Arnett, S., Bukhari, W., Jimenez Sanchez, S., O'Gorman, C., Sun, J., Prain, K., Woodhall, M., Silvestrini, R., Dale, R., Fulcher, D., Hawke, S., Heard, R., Lin, M., Pollard, J., Reddel, S., Spies, J., Vucic, S., Barnett, M., Parratt, J., et al (2020). Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation. Frontiers in Neurology, 11, 1-8. [More Information]
• Bukhari, W., Clarke, L., O'Gorman, C., Khalilidehkordi, E., Arnett, S., Prain, K., Woodhall, M., Silvestrini, R., Bundell, C., Ramanathan, S., Dale, R., Fulcher, D., Hawke, S., Heard, R., Pollard, J., Brilot-Turville, F., Barnett, M., Spies, J., et al (2020). The clinical profile of NMOSD in Australia and New Zealand. Journal of Neurology, 267(5), 1431-1443. [More Information]

2018

• Ramanathan, S., Mohammad, S., Tantsis, E., Nguyen, T., Merheb, V., Fung, V., White, O., Broadley, S., Lechner-Scott, J., Vucic, S., Henderson, A., Barnett, M., Reddel, S., Brilot-Turville, F., Dale, R. (2018). Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. Journal of Neurology, Neurosurgery and Psychiatry, 89(2), 127-137. [More Information]

2016

• Ramanathan, S., Prelog, K., Barnes, E., Tantsis, E., Reddel, S., Henderson, A., Vucic, S., Gorman, M., Benson, L., Alper, G., Barnett, M., Parratt, J., Hardy, T., Merheb, V., Nosadini, M., Fung, V., Brilot-Turville, F., Dale, R., et al (2016). Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Multiple Sclerosis Journal, 22(4), 470-482. [More Information]

2014

• Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology, 151(1), 16-24. [More Information]

2009

• Henderson, A., Barnett, M., Parratt, J., Prineas, J. (2009). Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Annals of Neurology, 66(6), 739-753. [More Information]

2006

• Barnett, M., Henderson, A., Prineas, J. (2006). The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis: clinical and laboratory research, 12(2), 121-132. [More Information]